Drug intelligence / Profile preview

LIVASTEP-M-KID

Development stage
Unknown
Lead developer
Varmed Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

LIVASTEP-M-KID is a fixed-dose combination pharmaceutical product marketed by Varmed Pharma, specifically designed for pediatric use. It combines levocetirizine, a second-generation H1-antihistamine, with montelukast, a cysteinyl leukotriene receptor antagonist (LTRA). Levocetirizine provides relief from allergic symptoms by selectively inhibiting peripheral H1 receptors, while montelukast blocks the CysLT1 receptor to prevent leukotriene-mediated airway inflammation and bronchoconstriction. This combination is indicated for the symptomatic treatment of allergic rhinitis and as an adjunctive therapy for asthma and other allergic airway diseases in children.

Brand names
LIVASTEP-M-KID
Other names
LIVASTEP M KIDLevocetirizine + Montelukast pediatric combination
02

Targets

CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on LIVASTEP-M-KID.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIVASTEP-M-KID.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call